Clinical Trials | September 28, 2022
South Korea nextgen sequencing tests market to grow at 4% CAGR during 2022-2030: GlobalData
There is also a growing interest in whole generation sequencing (WGS)
There is also a growing interest in whole generation sequencing (WGS)
This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.
The hospital is being constructed at an estimated cost of around Rs. 6,000 crore and will provide healthcare facilities to the people of Faridabad and the entire NCR region
Collaboration focuses on developing and implementing real-world research to drive patient access to cancer medicines
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
India’s first oncology laboratory for comprehensive Cancer Diagnostic services
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
Investment with representation on the Board of Directors and technical know-how
Abevmy follows the launch of the company’s two oncology biosimilars in Canada, Ogivri (bTrastuzumab) in 2019 – the first Trastuzumab approved in the country – and Fulphila (bPegfilgrastim), which was launched in 2020
Quantib Prostate is an AI-based software solution that advances the MRI prostate reporting workflow and is accessible directly from the radiologist's reading station
Subscribe To Our Newsletter & Stay Updated
